Stay updated on Decitabine Combo With Venetoclax for AML Clinical Trial
Sign up to get notified when there's something new on the Decitabine Combo With Venetoclax for AML Clinical Trial page.

Latest updates to the Decitabine Combo With Venetoclax for AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 was added and v3.3.1 removed, a minor UI/version-tracking update that does not affect content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedNew: Revision: v3.3.1 is displayed on the page. The previous revision label, Revision: v3.2.0, is removed.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded substantive study-record content: Adverse Events, Outcome Measures, Outcome Measures (Results), and an updated Study Status, with a Returned version showing ongoing QC. A government-operating-status notice was removed.SummaryDifference2%

- Check43 days agoChange DetectedVersion 2025-09-29 adds core content sections including Study Status, Document Section, Outcome Measures, Baseline Characteristics, Adverse Events, and Participant Flow. A later update on 2025-10-28 indicates Quality Control Review Has Not Concluded.SummaryDifference1%

- Check71 days agoChange DetectedResults availability updated with a new revision (v3.2.0) and removal of the prior “No Results Posted” status; includes funding/status notices relevant to reliability.SummaryDifference13%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.3%

Stay in the know with updates to Decitabine Combo With Venetoclax for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Decitabine Combo With Venetoclax for AML Clinical Trial page.